| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
26,020,000 |
| Market
Cap: |
245.11(M) |
| Last
Volume: |
6,675 |
Avg
Vol: |
6,656 |
| 52
Week Range: |
$6.48 - $11.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Home Health Care |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fennec Pharmaceuticals is a biopharmaceutical company focused on the development of PEDMARK™ (sodium thiosulfate anhydrous injection) for the prevention of platinum-induced ototoxicity in pediatric cancer patients. Co. has licensed from Oregon Health & Science University intellectual property rights for the use of PEDMARK™ as a chemoprotectant and is developing PEDMARK™ as a protectant against the hearing loss caused by platinum-based anti-cancer agents in children.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
41,667 |
41,667 |
41,667 |
41,667 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
384,683 |
445,042 |
481,476 |
532,549 |
| Total Sell Value |
$3,266,840 |
$3,836,454 |
$4,152,217 |
$4,642,390 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
18 |
24 |
31 |
38 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Frank Morgan C. |
10% Owner |
– – • |
2018-02-28 |
4 |
S |
$9.41 |
$160,911 |
I/I |
(17,100) |
2,183,397 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-02-28 |
4 |
S |
$9.26 |
$240,760 |
D/D |
(26,000) |
166,666 |
|
- |
|
| Cavazza Preta Martina |
10% Owner |
– – • |
2017-12-12 |
4 |
B |
$8.50 |
$2,499,978 |
D/D |
294,115 |
3,225,694 |
2.45 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-10-24 |
4 |
B |
$10.23 |
$20,460 |
D/D |
2,000 |
1,674,614 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-10-24 |
4 |
B |
$10.23 |
$20,460 |
I/I |
2,000 |
2,200,497 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-10-19 |
4 |
B |
$10.52 |
$13,676 |
D/D |
1,300 |
1,672,614 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-10-19 |
4 |
B |
$10.52 |
$13,676 |
I/I |
1,300 |
2,198,497 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-10-18 |
4 |
B |
$10.46 |
$209,357 |
D/D |
20,015 |
1,671,314 |
2.45 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-10-18 |
4 |
B |
$10.46 |
$209,357 |
I/I |
20,015 |
2,197,197 |
1.5 |
- |
|
| Sigma Tau Finanziaria Spa |
10% Owner |
– – • |
2017-09-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,931,579 |
|
- |
|
| Southpoint Master Fund, Lp |
10% Owner |
– – • |
2017-09-11 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
3,997,214 |
|
- |
|
| Clark John Smith Ii |
10% Owner |
– – • |
2017-09-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,997,214 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-17 |
4 |
B |
$4.04 |
$808 |
D/D |
200 |
1,651,299 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-17 |
4 |
B |
$4.04 |
$808 |
I/I |
200 |
2,177,182 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-13 |
4 |
B |
$4.38 |
$438 |
D/D |
100 |
1,651,099 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-13 |
4 |
B |
$4.38 |
$438 |
I/I |
100 |
2,176,982 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-12 |
4 |
S |
$3.45 |
$690 |
D/D |
(200) |
1,650,999 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-12 |
4 |
S |
$3.45 |
$690 |
I/I |
(200) |
2,176,882 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-05 |
4 |
B |
$3.45 |
$2,070 |
D/D |
600 |
1,651,199 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-05 |
4 |
B |
$3.45 |
$2,070 |
I/I |
600 |
2,177,082 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-04 |
4 |
B |
$3.39 |
$2,034 |
D/D |
600 |
1,650,599 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-04-04 |
4 |
B |
$3.39 |
$2,034 |
I/I |
600 |
2,176,482 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-03-31 |
4 |
B |
$2.97 |
$13,212 |
D/D |
4,400 |
1,649,999 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-03-31 |
4 |
B |
$2.97 |
$13,212 |
I/I |
4,400 |
2,175,882 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-03-30 |
4 |
B |
$2.80 |
$1,960 |
D/D |
700 |
1,645,599 |
2.37 |
- |
|
268 Records found
|
|
Page 5 of 11 |
|
|
0.15 (1.62%) 
